Adaptive Biotechnologies Corporation Common Stock (1HM)
XDUS
22.85
+0.15 (+0.66%)
Closed
Oct 14, 2026
Day's Range
22.2323.07
52 wk Range
10.5326.29
Financial Statements - 1HM - Adaptive Biotechnologies Corporation Common Stock
Revenue
276.97M▲ 82.6%
Net Income
-59.45M▲ 56.0%Net Margin -21.5%
EBITDA
-29.84M▲ 71.0%
Free Cash Flow
-48.94M▲ 41.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 276.97M | 151.64M | 170.27M | 185.30M | 154.34M | 98.38M |
| Cost of Goods | 71.35M | 61.08M | 75.55M | 57.90M | 49.30M | 22.53M |
| Gross Profit | 205.61M | 90.56M | 94.72M | 127.39M | 105.04M | 75.85M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -57.12M | -131.64M | -201.60M | -200.18M | -208.96M | -152.81M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | -6.10M | -25.42M | - | - | - |
| Pre Tax Income | -59.45M | -135.24M | -225.30M | -200.36M | -207.29M | -146.22M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -59.45M | -135.24M | -225.30M | -200.36M | -207.29M | -146.22M |
| EPS Basic | -0.39 | -1.08 | -1.56 | -1.4 | -1.48 | -1.11 |
| EPS Diluted | -0.39 | -1.08 | -1.56 | -1.4 | -1.48 | -1.11 |
| Basic Shares Outstanding | 151.72M | 124.65M | 151.40M | 148.31M | 146.07M | 136.55M |
| Diluted Shares Outstanding | 151.72M | 124.65M | 151.40M | 148.31M | 146.07M | 136.55M |
| Ebit | -47.67M | -125.42M | -211.50M | -196.13M | -207.29M | -152.81M |
| Ebitda | -29.84M | -103M | -163.84M | -175.21M | -193.34M | -144.34M |
| Net Income Continuous Operations | -59.45M | -135.24M | -225.30M | -200.36M | -207.29M | -146.22M |
| Minority Interests | -42K | 103K | 54K | 177K | 19K | - |
| Preferred Stock Dividends | - | - | - | - | - | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
